Palo Alto, CA, United States of America

Inna Vainshtein

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Discoverx Corporation. Active years: 2004-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inna Vainshtein. Retrieved from https://idiyas.com/inventor/inna-vainshtein-lfymjfmb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2004-2009

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inna Vainshtein: Innovator in Genetic Monitoring Systems

Introduction

Inna Vainshtein is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of innovative systems for monitoring genetic constructs and identifying enzyme inhibitors. With a total of 2 patents, her work is paving the way for advancements in molecular biology.

Latest Patents

Inna's latest patents include a "Genetic Construct Intracellular Monitoring System." This system provides an enzyme donor (ED) fused to a surrogate of a mammalian protein of interest, where the fusion protein retains the function of the natural protein. The invention includes a vector comprising a regulatory region functional in a mammalian host cell, a sequence encoding the ED joined to a multiple cloning site, an enzyme acceptor (EA) protein, and a substrate for the enzyme formed by ED and EA.

Another notable patent is for "Screening for Enzyme Inhibitors." This system employs a conjugate of a known inhibitor of a target enzyme and an enzyme donor, along with an enzyme acceptor that binds to the enzyme donor to form an active indicator-enzyme complex. The methodology allows for the identification of enzyme inhibitors by measuring the rate of product formation or substrate depletion catalyzed by the indicator enzyme, particularly for target enzymes that have substrates or products that are difficult to synthesize and/or detect.

Career Highlights

Inna Vainshtein is currently associated with DiscoverX Corporation, where she continues to innovate and contribute to the field of biotechnology. Her work is characterized by a strong focus on practical applications that can lead to significant advancements in medical and scientific research.

Collaborations

Inna collaborates with talented professionals such as Riaz Rouhani and Sharon Zhao, enhancing the innovative environment at DiscoverX Corporation. Their combined expertise fosters a culture of creativity and scientific exploration.

Conclusion

Inna Vainshtein's contributions to biotechnology through her patents and collaborative efforts exemplify the impact of innovative thinking in scientific research. Her work continues to inspire advancements in genetic monitoring and enzyme inhibition, showcasing the importance of innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…